Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 73.68% is 219% above its 3-year average of 23.08%, near the high end of its 3-year range (0.00%–75.00%).
50.32% above its 12-month average of 49.01%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 63.30%.
GROSS MARGIN
73.68%
GROSS MARGIN AVG TTM
49.01%
GROSS MARGIN AVG 3Y
23.08%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
-28.46%
GROSS MARGIN AVG 15Y
47.40%
GROSS MARGIN AVG 20Y
53.21%
CURRENT VS TTM AVG
+50.32%
CURRENT VS 3Y AVG
+219.21%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+358.87%
CURRENT VS 15Y AVG
+55.45%
CURRENT VS 20Y AVG
+38.46%
SECTOR MEDIAN · HEALTHCARE
40.32%
median of 697 covered companies
CURRENT VS SECTOR MEDIAN
+82.74%
vs the sector median at left
Abeona Therapeutics Inc.
Market Cap
$289.25M
Gross Margin
73.68%
TTM Avg
49.01%
3Y Avg
23.08%
5Y Avg
0.00%
Market Cap
$290.79M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$285.94M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$290.97M
Gross Margin
49.14%
TTM Avg
49.09%
3Y Avg
45.86%
5Y Avg
49.48%
Market Cap
$284.21M
Gross Margin
0.00%
TTM Avg
10.38%
3Y Avg
-887.42%
5Y Avg
-730.43%
Market Cap
$297.62M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$280.60M
Gross Margin
42.62%
TTM Avg
48.63%
3Y Avg
38.13%
5Y Avg
25.55%
Market Cap
$278.87M
Gross Margin
-94.12%
TTM Avg
-431.85%
3Y Avg
-231.35%
5Y Avg
-189.25%
Market Cap
$276.08M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abeona Therapeutics Inc. (ABEO) | $289.25M | 73.68% | 49.01% | 23.08% | 0.00% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Standard BioTools Inc. (LAB)vs › | $290.97M | 49.14% | 49.09% | 45.86% | 49.48% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $284.21M | 0.00% | 10.38% | -887.42% | -730.43% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aurora Cannabis Inc. (ACB)vs › | $280.60M | 42.62% | 48.63% | 38.13% | 25.55% |
| Fate Therapeutics, Inc. (FATE)vs › | $278.87M | -94.12% | -431.85% | -231.35% | -189.25% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $276.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| Benitec Biopharma Inc. (BNTC)vs › | $303.53M | 0.00% | 0.00% | 25.00% | 13.20% |
Gross Margin
73.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 63.30% |
| 2026-03-31 | 59.12% |
| 2025-12-31 | 47.66% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 75.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 55.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -9270.59% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -600.80% |
| 2022-03-31 | -2947.69% |
| 2021-12-31 | -326.77% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | -13.84% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 545.02% |
| 2018-09-30 | -669.46% |
| 2018-06-30 | -2768.12% |
| 2018-03-31 | -1437.10% |
| 2017-12-31 | -2553.95% |
| 2017-09-30 | -1396.35% |
| 2017-06-30 | -2576.50% |
| 2017-03-31 | -1081.72% |
| 2016-12-31 | 100.00% |
| 2016-09-30 | 100.00% |
| 2016-06-30 | 100.00% |
| 2016-03-31 | 100.00% |
| 2015-12-31 | 100.00% |
| 2015-09-30 | 100.00% |
| 2015-06-30 | 100.00% |
| 2015-03-31 | 100.00% |
| 2014-12-31 | 100.00% |
| 2014-09-30 | 100.00% |
| 2014-06-30 | 100.00% |
| 2014-03-31 | 100.00% |
| 2013-12-31 | -76983.33% |
| 2013-09-30 | 96.30% |
| 2013-06-30 | 88.65% |
| 2013-03-31 | 94.69% |
| 2012-12-31 | 93.44% |
| 2012-09-30 | 90.93% |
| 2012-06-30 | 90.87% |
| 2012-03-31 | 95.85% |
| 2011-12-31 | 20.16% |
| 2011-09-30 | 94.14% |
| 2011-06-30 | -76.16% |
| 2011-03-31 | 38.67% |
| 2010-12-31 | 4.76% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 162.87% |
| 2005-09-30 | 48.10% |
| 2005-06-30 | 28.51% |
| 2005-03-31 | 34.19% |
| 2004-12-31 | 48.55% |
| 2004-09-30 | 78.38% |
| 2004-06-30 | 54.41% |
| 2004-03-31 | -30.00% |
| 2003-12-31 | 83.65% |
| 2003-09-30 | -172.73% |
| 2003-06-30 | 84.77% |
| 2003-03-31 | 72.26% |
| 2002-12-31 | 84.19% |
| 2002-09-30 | 100.00% |
